The Association Between Blood Eosinophilsp in Thai COPD Patients: A Prospective Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

145 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-12-01

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The association of blood eosinophil as a biomarker for eosinophilic Thai COPD patients, such as COPD exacerbation, hospital admission, lung functions and mortlity.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Observational Study to Evaluate Health Status of Chronic Obstructive Pulmonary Disease (COPD) Patients in Response to Real-life Treatments in Thailand

NCT01169727

Chronic Obstructive Pulmonary Disease

COMPLETED

Role of Inhaler Adherence and Blood Eosinophil Count in Exacerbations of COPD

NCT05814484

Chronic Obstructive Pulmonary Disease Adherence, Treatment

UNKNOWN

Eosinopenia in Severe COPD Exacerbation

NCT06188065

Chronic Obstructive Pulmonary Disease

RECRUITING

Changes in Cytokine Levels During an Acute Exacerbation of Chronic Obstructive Pulmonary Disease

NCT00281242

Pulmonary Disease, Chronic Obstructive Lung Diseases, Obstructive

COMPLETED

Evaluation of Eosinophil Phenotype in COPD Patients

NCT04494308

COPD COPD Exacerbation

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The prospective one year study in Thai COPD patients for the clinical outcomes of COPD compare between eosinophilic and non-eosinophilic which determine by blood eosinophil counts equal or more than 300 cells/microliters. The primary outcomes was COPD exacerbation, the secondary outcomes were lung function, dyspnea and quality of life.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Copd

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

eosinophilic COPD patient

COPD patient with blood eosinophil equal or \> 300 cells/µL

observatory

Intervention Type OTHER

observation for 1 year period

non-eosinophilic COPD patient

COPD patient with blood eosinophil \< 300 cells/µL

observatory

Intervention Type OTHER

observation for 1 year period

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

observatory

observation for 1 year period

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

clinical outcomes

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* diagnosis of COPD by GOLD criteria

Exclusion Criteria

1. high blood eosinophil from known causes such as systemic corticosteroid use, malignancy, parasitic infection
2. Patients who had previous acute exacerbation within 30-day before study entry
3. Patients who had previous systemic corticosteroids used within 30-day before study entry

Minimum Eligible Age

40 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No